Company / Inventory per Share
Protalix BioTherapeutics, Inc. Inventory per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$0.34
FY2025
5-year range
$0.29 / $0.52
FY2021-FY2025
Trend
+16.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Inventory per Share returned to growth in FY2025 after 4 years of decline, reaching $0.34.
Based on SEC 10-K filings.
0.34 in FY2025 with a 10-year CAGR of +18.6%.
Declined from $0.35 to $0.34 over the past 2 years.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- -2.8%
- 5-Year CAGR
- -17.4%
- 10-Year CAGR
- +18.6%
Key checks
Key Insights
- In FY2025, inventory per share increased 16.5% year-over-year.
- Peak inventory per share was recorded in FY2020.
- Lowest inventory per share in the period was in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.34 | +16.5% |
| FY2024 | $0.29 | -17.8% |
| FY2023 | $0.35 | -4.0% |
| FY2022 | $0.37 | -28.6% |
| FY2021 | $0.52 | -41.4% |
| FY2020 | $0.88 | +60.4% |
| FY2019 | $0.55 | +771.0% |
| FY2017 | $0.06 | +20.1% |
| FY2016 | $0.05 | -14.7% |
| FY2015 | $0.06 | -13.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026